Alex Herrera, MD, City of Hope, Duarte, CA, gives an overview of a study which evaluated the safety and efficacy of allogeneic stem cell transplantation (alloSCT) in patients with large B-cell lymphoma (LBCL) who progressed after CAR-T cell therapy. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.